Design Portfolio

Creating a character driven story for patient education and treatment adherence

Managing sickle cell disease in children is challenging, due to various factors such as cultural, societal, and parental concerns. These factors often hinder early treatment initiation, despite the well-documented long-term benefits. Medication adherence also poses a significant challenge once treatment has commenced.

Gaining national media coverage for a non-invasive treatment technology

Polyphotonix wanted to raise awareness of their NHS partnership for the use of their Noctura 400 mask; which utilises green light to treat diabetic retinopathy in those suffering from Diabetes while they sleep. Onyx Health were tasked with gaining national attention for Polyphotonix’s pioneering mask to further opportunities for similar adoption. 

Polyphotonix specifically requested national coverage of the partnership, citing The Mail on Sunday and local paper Northern Echo as their key targets.

Creating content to raise a products profile

Zilico’s flagship product ZedScan, can identify potential areas of disease in the cervix earlier than traditional colposcopy methods, which have remained relatively unchanged for decades. Messaging needed to be carefully considered so as not to alienate colposcopists by suggesting they were misdiagnosing.

Creative thinking to launch an innovative medical device in the US

SAFIRA, a tool born from medical device innovation, that improves anaesthetic delivery by regulating the pressure by which anaesthetic is administered for regional anaesthesia, was set to launch in the US. Our client, Medovate, wanted a creative concept and marketing assets to generate interest at a medical congress, but due to COVID-19, the congress was cancelled and we needed to adapt.

Sparking a renewed interest in an established treatment

The cardiovascular treatment and prevention pathway is well established, but with relatively little innovation, keeping treatments front of mind was challenging. There is a grey area in current risk reduction guidelines, where clinicians require more guidance when making prescribing decisions.

A global campaign to help HCPs see the world through the eyes of the patient

We were approached by a global pharma company to help promote their antihistamine product to HCPs. The aim was to communicate the allergy relief benefits for children and adolescents, when compared to competitor products, and drive HCP recommendations

Developing a new brand for a change of focus

Actigen wanted to establish themselves as an expert partner with which to conduct clinical trials in preparation to launch their first clinical trial.

Developing medical education programmes

To increase the availability of a niche drug in European clinical institutions, we work with influential UK and EU chemotherapy nurses to provide a robust education programme, to train nurses and pharmacists in chemotherapy extravasation management.

A campaign to launch a new pharmaceutical product

Following a new indication for an oral solution used to treat severe paediatric hypersalivation, Colonis Pharma Limited approached Onyx Health to create a full two-phase launch strategy and a library of materials to accompany the launch.

A strategy for an unlicensed medicine supplier

To position UL Medicines, a relative newcomer to the unlicensed market, as the go-to company for the supply of all imported unlicensed medicines and specialist products.

Creating a social media presence for Suu Balm

Our client, based in Singapore, required a reliable partner to successfully launch Suu Balm, a fast itch relieving moisturising cream to consumers unfamiliar with the brand.

Managing sales for medical technology

Our challenge was to engage with Trust decision-makers to help them understand the cost-efficiency savings that could be made, which in turn would improve patient outcomes.